Saad ED - Search Results

1

Brazilian Validation of the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Group (QLG) Computerised Adaptive Tests (CAT) Core.

Marta GN, de Souza TYT, Silva ARNSE, Pereira APA, Ferreira Neto DR, Asso RN, Degrande FAM, Nader-Marta G, da Silva MF, Gadia R, Hanna SA, Holzner B, Saad ED, Petersen MA. Marta GN, et al. Among authors: saad ed. Curr Oncol. 2021 Aug 31;28(5):3373-3383. doi: 10.3390/curroncol28050291. Curr Oncol. 2021. PMID: 34590597 Free PMC article.

2

Treatment priorities in oncology: do we want to live longer or better?

Marta GN, Del Nero LG, Marta GN, Mangabeira A, Critchi G, Kovács MJ, Silva JL, Saad ED. Marta GN, et al. Among authors: saad ed. Clinics (Sao Paulo). 2014 Aug;69(8):509-14. doi: 10.6061/clinics/2014(08)02. Clinics (Sao Paulo). 2014. PMID: 25141108 Free PMC article.

3

Assessment of quality of life in phase III trials of radiotherapy in localized or locally advanced head and neck cancer over the past 17 years.

Marta GN, Saad ED. Marta GN, et al. Among authors: saad ed. Ann Palliat Med. 2017 Jan;6(1):73-80. doi: 10.21037/apm.2016.11.09. Ann Palliat Med. 2017. PMID: 28209070 Free article. Review.

4

Assessment of quality of life in advanced non-small-cell lung cancer: an overview of recent randomized trials.

Saad ED, Adamowicz K, Katz A, Jassem J. Saad ED, et al. Cancer Treat Rev. 2012 Oct;38(6):807-14. doi: 10.1016/j.ctrv.2012.02.012. Epub 2012 Mar 23. Cancer Treat Rev. 2012. PMID: 22445316 Review.

5

Health-related quality of life assessment in contemporary phase III trials in advanced colorectal cancer.

Adamowicz K, Saad ED, Jassem J. Adamowicz K, et al. Among authors: saad ed. Cancer Treat Rev. 2016 Nov;50:194-199. doi: 10.1016/j.ctrv.2016.09.015. Epub 2016 Sep 30. Cancer Treat Rev. 2016. PMID: 27718458 Review.

6

Formal statistical testing and inference in randomized phase II trials in medical oncology.

Saad ED, Sasse EC, Borghesi G, Miranda VC, Fede AB, Saad LS, Oliveira V, Barros EA, Pascoin M, Del Giglio A, Riechelmann R. Saad ED, et al. Among authors: saad ls. Am J Clin Oncol. 2013 Apr;36(2):143-5. doi: 10.1097/COC.0b013e3182436e6c. Am J Clin Oncol. 2013. PMID: 22307212

7

Sample Size Calculation in Oncology Trials: Quality of Reporting and Implications for Clinical Cancer Research.

Bariani GM, de Celis Ferrari AC, Precivale M, Arai R, Saad ED, Riechelmann RP. Bariani GM, et al. Among authors: saad ed. Am J Clin Oncol. 2015 Dec;38(6):570-4. doi: 10.1097/01.coc.0000436085.23342.2d. Am J Clin Oncol. 2015. PMID: 24401665

8

Neoadjuvant as Future for Drug Development in Breast Cancer--Letter.

Buyse M, Burzykowski T, Saad ED. Buyse M, et al. Among authors: saad ed. Clin Cancer Res. 2016 Jan 1;22(1):268. doi: 10.1158/1078-0432.CCR-15-1047. Clin Cancer Res. 2016. PMID: 26728410 No abstract available.

9

Disease-free survival as a surrogate for overall survival in patients with HER2-positive, early breast cancer in trials of adjuvant trastuzumab for up to 1 year: a systematic review and meta-analysis.

Saad ED, Squifflet P, Burzykowski T, Quinaux E, Delaloge S, Mavroudis D, Perez E, Piccart-Gebhart M, Schneider BP, Slamon D, Wolmark N, Buyse M. Saad ED, et al. Lancet Oncol. 2019 Mar;20(3):361-370. doi: 10.1016/S1470-2045(18)30750-2. Epub 2019 Jan 29. Lancet Oncol. 2019. PMID: 30709633 Free PMC article.

10

Statistical aspects in adjuvant and neoadjuvant trials for gastrointestinal cancer in 2020: focus on time-to-event endpoints.

Saad ED, Buyse M. Saad ED, et al. Curr Opin Oncol. 2020 Jul;32(4):384-390. doi: 10.1097/CCO.0000000000000636. Curr Opin Oncol. 2020. PMID: 32541329 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

91 results

Search Page